Protalix BioTherapeutics, Inc.PLXNYSE
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending lower, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$29.08M
↑ 15% above average
Average (9y)
$25.27M
Historical baseline
Range
High:$52.02M
Low:$801000.00
CAGR
+26.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $29.08M | -31.6% |
| 2023 | $42.51M | +51.6% |
| 2022 | $28.05M | +27.5% |
| 2021 | $22.00M | -57.7% |
| 2020 | $52.02M | +18.8% |
| 2019 | $43.80M | +75.6% |
| 2018 | $24.94M | +326.5% |
| 2017 | $5.85M | +630.0% |
| 2016 | $801000.00 | -78.0% |
| 2015 | $3.63M | - |